| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 02/17/2005 | US20050037067 3,7-Diazabicyclo [3.3.1]formulations as anti-arrhythmic compounds |
| 02/16/2005 | EP1506202A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof |
| 02/16/2005 | EP1506175A1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 02/16/2005 | EP1505963A1 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1505930A2 Drug-delivery endovascular stent and method for treating restenosis |
| 02/16/2005 | EP1419167B1 1-(2,5'-anhydro-lyxofuranosyl) thymines for the synthesis of radiomarked fluoro-3' deoxynucleotides |
| 02/16/2005 | CN1582150A Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 02/15/2005 | US6855830 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855708 N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
| 02/15/2005 | CA2323720C New substances derived from aza-indolic polycyclics, processes for preparing them and pharmaceutical compounds containing them |
| 02/10/2005 | WO2005012294A1 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 02/10/2005 | WO2004113357A3 Nucleoside analog inhibitors of reverse transcriptase |
| 02/10/2005 | US20050033046 Regioselective synthesis of CCI-779 |
| 02/10/2005 | US20050032866 Administering N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide or salt as antiarrhythmia agent |
| 02/10/2005 | US20050032860 CBI analogs of CC-1065 and the duocarmycins |
| 02/10/2005 | US20050032826 Medical devices containing rapamycin analogs |
| 02/10/2005 | US20050032825 rapamaycin derivatives used as fungicides, anticarcinogenic agents, immunosuppressants or as coatings on drug eluting stents to prevent restenosis |
| 02/10/2005 | US20050032777 benzyl carbamates and ureas such as 5-(4-(4-cyclopropylmethylpiperazine-1-carbonylaminomethyl)-3-methylbenzoyl)-1-methyl-4,10-dihydropyrazolo[5,4-b][1,5]benzodiazepine, used for treatment of sexual disorders |
| 02/10/2005 | US20050031627 Methods for preparing immunoconjugates |
| 02/10/2005 | DE10331675A1 Hetarylsubstituierte Pyrazolidindion-Derivate Hetarylsubstituierte pyrazolidindione derivatives |
| 02/09/2005 | EP1504010A1 Vitamin-mitomycin conjugates |
| 02/09/2005 | EP1503997A1 Cysteine protease inhibitors |
| 02/09/2005 | EP1453813A4 IMPROVED PURIFICATION OF 4, 4'(5')-DI- i t /i -BUTYLCYCLOHEXANO-18-CROWN-6 |
| 02/09/2005 | EP1349839B1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578625A Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852729 Macrolides |
| 02/08/2005 | US6852715 Formula (1) wherein R1 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon atoms; and R2 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon |
| 02/03/2005 | WO2005010015A1 Method of purifying macrolides |
| 02/03/2005 | WO2005010010A1 Cci-779 isomer c |
| 02/03/2005 | WO2005010009A1 Thienopyridine and furopyridine kinase inhibitors |
| 02/03/2005 | WO2005009398A2 Tetracyclic benzamide derivatives and methods of use thereof |
| 02/03/2005 | WO2005009384A2 Egfr tyrosine kinase inhibitors |
| 02/03/2005 | WO2003106450A8 Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 02/03/2005 | US20050027119 Methyl (2S)-2-(2,3,4-trifluoroanilino)propionate from 2,3,4-trifluoroaniline and an acetic acid ester in the presence of a metal catalyst under a hydrogen gas; antibacterial agents |
| 02/03/2005 | US20050027112 Using sorptive resin bed comprised of amberlite as tool in isolation of tacrolimus from solution; antibiotic purification |
| 02/03/2005 | US20050026944 Thienopyridine and furopyridine kinase inhibitors |
| 02/03/2005 | US20050026943 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 02/03/2005 | US20050026927 Pyrazole derivatives as psychopharmaceuticals |
| 02/03/2005 | US20050026922 For treating CNS or other disorders, including concurrent treatment of disorders such as schizophrenia and depression; side effect reduction; for example, (7R,9aS)-trans-7-[6-(2,6-Dimethyl-piperidin-1-ylmethyl)-pyridin-2-yloxymethyl]-2-(5-fluoro-benzo[d]isoxazol-3-yl)-octahydro-pyrido[1,2-a]pyrazine |
| 02/03/2005 | US20050026901 Antihistaminic spiro compounds |
| 02/03/2005 | US20050025992 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 02/03/2005 | CA2532982A1 Thienopyridine and furopyridine kinase inhibitors |
| 02/03/2005 | CA2528173A1 Cci-779 isomer c |
| 02/03/2005 | CA2517260A1 Tetracyclic benzamide derivatives and methods of use thereof |
| 02/02/2005 | EP1501835A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/02/2005 | EP1501809A1 Triazole derivatives as tachykinin receptor antagonists |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/01/2005 | US6849647 Amide compounds and medications containing the same technical field |
| 02/01/2005 | US6849620 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 02/01/2005 | US6849619 Substituted pyridoindoles as serotonin agonists and antagonists |
| 01/27/2005 | WO2005007658A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007655A1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds |
| 01/27/2005 | WO2005007630A2 Aryl fused azapolycyclic compounds |
| 01/27/2005 | WO2005007629A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 01/27/2005 | WO2004082606A3 Fused pyrrole compounds |
| 01/27/2005 | WO2004071345A3 A device and method for the determination of lithium ion concentration in a biological fluid |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020830 Heteroaryl fused azapolycyclic compounds |
| 01/27/2005 | US20050020616 Central nervous system and psychological disorders |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020572 Therapy for bacteria infections |
| 01/27/2005 | US20050020570 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 01/27/2005 | CA2533100A1 Aryl fused azapolycyclic compounds |
| 01/27/2005 | CA2529193A1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/26/2005 | CN1186020C Acylbenzoxazine for enhancing synaptic response(s) |
| 01/25/2005 | US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/20/2005 | WO2005005435A1 Spiro ′1-azabicyclo ′2.2.2!octan-3,5′-oxazolidin -2′-one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor |
| 01/20/2005 | WO2005005434A1 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 01/20/2005 | WO2005005428A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 01/20/2005 | WO2005005397A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | WO2004106385A3 Monoclonal antibodies specific for buprenorphine and metabolites thereof |
| 01/20/2005 | US20050014940 Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines intermediates therefore, and processes for preparing such intermediates |
| 01/20/2005 | US20050014809 Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones |
| 01/20/2005 | US20050014777 Antitumor agents; anticancer agents; leukemia; central nervous system; mammary glands; prostate glands; skins |
| 01/20/2005 | US20050014769 Anticancer agents; controlling apoptosis |
| 01/20/2005 | US20050014754 Anticancer agents; antiinflammatory agents; autoimmune disease |
| 01/20/2005 | US20050014700 Cbi analogues of cc-1065 and the duocarmycins |
| 01/20/2005 | DE10329860A1 Sulfonamidderivate polycyclischer Farbstoffe für analytische Anwendungen Sulfonamide derivatives of polycyclic dyes for analytical applications |
| 01/20/2005 | CA2531510A1 Spiro '1-azabicyclo '2.2.2!octan-3,5'-oxazolidin-2'one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor |
| 01/20/2005 | CA2530450A1 5-substituted quinazolinone derivatives |
| 01/19/2005 | EP1497297A1 Polymorph of ascomycin derivative |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1313738A4 Process for the preparation and purification of thiol-containing maytansinoids |
| 01/19/2005 | EP0994880B1 Crystalline macrolides and process for their preparation |
| 01/19/2005 | CN1566117A Fluorine quinolone compounds and synthetic method thereof |
| 01/19/2005 | CN1185545C Silver halide picture photosensitive material |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/19/2005 | CN1185216C Fungicides |
| 01/18/2005 | US6844342 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 01/18/2005 | US6844089 Organic red electro-luminescent device and dopant |
| 01/13/2005 | WO2005003123A1 Novel pyridine derivatives as jnk specific inhibitors |
| 01/13/2005 | WO2005003086A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 01/13/2005 | WO2005002577A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | WO2005002503A2 Asymmetric benzimidazoles and related compounds as potassium channel modulators |